Famotidine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Famotidine is a non-sedating antihistamine that blocks the H2 histamine receptor. Famotidine is available over the counter and on perscription and is used to treat and prevent ulcers, gastroesophageal reflux disease (GERD) and other conditions that cause heartburn.[1]

Famotidine brand names include Pepcid and Zantac 360 (not to be confused with Zantac, which contains different active ingredients).[1][2][3]

Theory

Evidence

Long COVID

Famotidine has limited evidence for use in Long COVID patients from a small observational study by Glynne et al. (2022), in which H1 and H2 blockers were used together.[4]

Clinicians

Risks and safety

Costs and availability

Available over the counter or on perscription.[1][3][2]

Notable studies

  • 2022, Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines[4] - (Full text)

See also

Learn more

References

  1. 1.0 1.1 1.2 "Famotidine Uses, Dosage & Side Effects". Drugs.com. Retrieved February 19, 2022.
  2. 2.0 2.1 "Famotidine - Uses, Side Effects, and More". WebMD. Retrieved February 19, 2022.
  3. 3.0 3.1 "Famotidine: Uses, Interactions, Mechanism of Action". Drugbank Online. Retrieved February 19, 2022.
  4. 4.0 4.1 Glynne, Paul; Tahmasebi, Natasha; Gant, Vanya; Gupta, Rajeev (January 2022). "Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines". Journal of Investigative Medicine. 70 (1): 61–67. doi:10.1136/jim-2021-002051. ISSN 1081-5589. PMC 8494538. PMID 34611034.